文献速递炎症性肠病

老年起病炎症性肠病的年龄相关及疾病相关并发症与死亡风险:一项基于人群的研究

Risk of Age-related and Disease-related Complications and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-03-13

基于以色列全国Epi-IIRN数据库,纳入2005至2020年诊断的2826例老年起病炎症性肠病(EO-IBD)患者,与非IBD老年人群及成人起病IBD(AO-IBD)患者匹配比较。EO-IBD患者死亡风险及年龄相关并发症风险与非IBD老年人相似;与AO-IBD相比,EO-IBD患者腹部手术风险更高,但肛周手术风险更低。

要点

  • 老年起病IBD患者死亡风险及肺炎、骨折、菌血症、血栓栓塞风险与非IBD老年人相似。
  • 老年起病IBD患者硫嘌呤和抗TNF药物暴露低于成人起病IBD患者。
  • 老年起病克罗恩病患者腹部手术风险高于成人起病者,但肛周手术风险更低。

核心结论

  • 与非IBD老年人相比,老年起病IBD患者死亡及并发症风险相似。
  • 与成人起病IBD相比,老年起病IBD患者腹部手术风险更高,但肛周手术风险不更高。

研究设计与样本

  • 以色列全国性队列研究(Epi-IIRN),纳入2005至2020年诊断的2826例老年起病IBD(≥65岁)患者。
  • 老年起病IBD患者与3倍年龄、性别、地区匹配的非IBD个体比较年龄相关结局。
  • 老年起病IBD患者与4倍按IBD亚型、性别、地区匹配的成人起病IBD(18-65岁)患者比较。
  • 采用累积发病率函数估计事件概率,以死亡作为竞争风险;采用比例子分布风险模型评估预测因素。

主要发现

  • 老年起病IBD与对照的死亡率分别为每1000人年292.32(95%CI 273.53-311.85)与291.24(95%CI 280.31-302.42),死亡原因相似。
  • 肺炎aHR 1.04(95%CI 0.84-1.29)、骨折aHR 1.03(95%CI 0.82-1.29)、菌血症aHR 2.16(95%CI 0.87-5.40)、血栓栓塞aHR 0.58(95%CI 0.27-1.23)。
  • 老年起病IBD较成人起病IBD硫嘌呤暴露aHR 0.44(95%CI 0.39-0.49),抗TNF暴露aHR 0.37(95%CI 0.32-0.42)。
  • 克罗恩病腹部手术aHR 1.23(95%CI 1.04-1.46),溃疡性结肠炎腹部手术aHR 1.51(95%CI 2.04-3.08),克罗恩病肛周手术HR 0.27(95%CI 0.16-0.47)。
  • 老年起病克罗恩病与成人起病克罗恩病3年重复肛周手术频率分别为7.1%与36%,重复腹部手术频率分别为29%与21%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In this nationwide cohort from Israel (Epi-IIRN), we aimed to characterize risks for age-related complications, mortality, and inflammatory bowel disease (IBD)-related surgeries in patients with elderly-onset IBD (EO-IBD). METHODS: Data of patients with EO-IBD (≥65 years) diagnosed during 2005 to 2020 were retrieved from the epi-IIRN database. Patients with EO-IBD were compared with 3 age-, sex-, and district-matched non-IBD individuals, for age-related outcomes. Patients with incident EO-IBD were matched to 4 adult-onset (AO) IBD (≥18-65 years) by IBD subtype, sex, and district. Cumulative incidence functions were calculated to estimate event probabilities over time, accounting for death as a competing risk. Proportional subdistribution hazards models were used to assess predictors of medication use, surgery, and complications. RESULTS: Of 2826 EO-IBD cases, 2162 had 3 matched non-IBD controls. Mortality rates per 1000 person-years (PY) were similar in EO-IBD and non-IBD controls (292.32; 95% confidence interval [CI], 273.53-311.85 vs 291.24; 95% CI, 280.31-302.42, respectively) as were mortality causes and risk for pneumonia (adjusted hazard rate [aHR], 1.04; 95% CI, 0.84-1.29), fractures (aHR, 1.03; 95% CI, 0.82-1.29), bacteremia (aHR, 2.16; 95% CI, 0.87-5.40), and thromboembolism (aHR, 0.58; 95% CI, 0.27-1.23). When matching 2826 patients with EO-IBD to 11,304 patients with AO-IBD, the EO-IBD group had lower exposure to thiopurines (aHR, 0.44; 95% CI, 0.39-0.49) and anti-tumor necrosis factor (TNF) (aHR, 0.37; 95% CI, 0.32-0.42) and higher risk for abdominal surgery (aHR, 1.23; 95% CI, 1.04-1.46) in Crohn's disease [CD]; aHR, 1.51; 95% CI, 2.04-3.08 in ulcerative colitis [UC], respectively) but lower perianal surgery risk (hazard ratio [HR], 0.27; 95% CI, 0.16-0.47) in CD. The calculated frequencies of repeat perianal and abdominal surgery in the EO-CD and AO-CD groups at 3 years were 7.1% and 36%, respectively, and 29% and 21%, respectively. CONCLUSIONS: Compared with non-IBD elderly, patients with EO-IBD have similar risks for death and complications. Compared with AO-IBD, patients with EO-IBD are at higher risk for abdominal surgery, but not for perianal surgery.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Ben Hur D, Issaschar G, Moshe R, et al. Risk of Age-related and Disease-related Complications and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Study. Clin Gastroenterol Hepatol. 2025. PMID: 40089251. doi:10.1016/j.cgh.2025.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。